Key Finding
The global burden of PCOS is increasing with onset concentrated in ages 10-19 and peak impact in ages 15-49, with projections showing continued escalation through 2035, particularly in lower-income countries.
Researchers analyzed data on polycystic ovary syndrome (PCOS) from 1990 to 2021 across countries worldwide to understand how this hormonal condition affects women globally and predict trends through 2035. PCOS causes irregular periods, fertility challenges, hormonal imbalances, and metabolic issues, impacting millions of women during their reproductive years.
The study found that PCOS cases are increasing worldwide, with symptoms typically beginning in the teenage years (ages 10-19) and the greatest health impact occurring during prime reproductive years (ages 15-49). Wealthier countries with better healthcare systems report higher rates of PCOS, likely because diagnosis is more available and standardized in these regions. However, these same countries have been more successful at managing the condition's growth. Significant disparities exist between nations, with lower-income countries facing challenges in diagnosis and treatment access.
The researchers identified two main reasons for rising PCOS rates: population growth and changes in how common the condition is becoming. They predict the burden will continue increasing through 2035, particularly in regions with limited healthcare resources.
What this means for patients: As awareness grows, more women may seek complementary treatments like acupuncture alongside conventional care. Research suggests acupuncture may help manage PCOS symptoms including irregular cycles, insulin resistance, and stress. The increasing global recognition of PCOS underscores the importance of integrative approaches that address hormonal balance, metabolic health, and emotional well-being. If you're considering acupuncture for PCOS, seek a licensed acupuncturist with experience treating reproductive and endocrine conditions.
This epidemiological study analyzed global PCOS burden from 1990-2021 using disability-adjusted life years (DALYs) and case numbers, with projections to 2035. Researchers examined data across socio-demographic indices (SDI), geographic regions, and age stratifications, conducting inequality analysis and decomposition modeling.
Key findings indicate PCOS onset peaks in the 10-19 age cohort, with maximum disease burden (DALYs and prevalence) in the 15-49 age group. Higher SDI countries demonstrate greater absolute PCOS burden but superior growth control compared to low SDI regions. Population growth and epidemiological shifts are primary drivers of increasing burden. Cross-national inequality persists, with projection models indicating continued burden escalation through 2035.
Clinical implications: Practitioners should recognize PCOS as an escalating global health concern requiring early intervention during adolescence. The study highlights disparities in diagnosis and management capacity, particularly in lower-resource settings. Acupuncture protocols addressing reproductive endocrine dysfunction, insulin sensitivity, and inflammatory markers may provide valuable adjunctive care, particularly where conventional resources are limited. Standardized diagnostic approaches and increased patient education remain critical needs.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Three distinct BNC1 gene variants contribute to premature ovarian insufficiency through different molecular mechanisms, with each variant affecting separate biological pathways including immune regulation, antiviral responses, and reproductive development.
📌 LbGP supplementation significantly improved oocyte quality in aged mice by restoring mitochondrial function through PPAR signaling activation and remodeling the ovarian microenvironment by reducing inflammation and increasing functional granulosa cells.
📌 Copper deficiency during pregnancy causes fetal growth restriction by disrupting placental structure, impairing trophoblast cell function, and dysregulating lipid metabolism in the placenta.